SUMO-1 CRISPR Knockout and Activation Products (h)

SUMO-1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human SUMO-1 gene expression

Frontiers SUMO-specific Isopeptidases Tuning Cardiac SUMOylation in Health and Disease

SUMO-1 CRISPR Knockout and Activation Products (h)

Molecules, Free Full-Text

Frontiers The SUMO E3 Ligase MdSIZ1 Sumoylates a Cell Number Regulator MdCNR8 to Control Organ Size

A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites

FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation

Reciprocal interplay between OTULIN–LUBAC determines genotoxic and inflammatory NF-κB signal responses

Alternative CRISPR Discovered @MIT Leaders in Pharmaceutical Business Intelligence (LPBI) Group

FAT10 inhibits SUMO activation by AOS1/UBA2. a In vitro

SUMO-1 CRISPR Knockout and Activation Products (h)

Mapping cellular responses to DNA double-strand breaks using CRISPR technologies: Trends in Genetics